The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern Venture Trust Regulatory News (NVT)

Share Price Information for Northern Venture Trust (NVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 56.00
Ask: 59.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.357%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
NVT Live PriceLast checked at -
Northern Venture Trust is an Investment Trust

To provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing primarily in unquoted UK manufacturing and service businesses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited Half-Yearly Financial Report for the Six Month Period Ended 30 September 2023

23 Nov 2023 14:00

Unaudited Half-Yearly Financial Report for the Six Month Period Ended 30 September 2023

23 NOVEMBER 2023

NORTHERN VENTURE TRUST PLC

UNAUDITED HALF-YEARLY FINANCIAL REPORT FOR THE SIX MONTH PERIOD ENDED 30 SEPTEMBER 2023

Northern Venture Trust PLC is a Venture Capital Trust (VCT) whose investment adviser is Mercia Fund Management Limited. The trust was one of the first VCTs launched on the London Stock Exchange in 1995. It invests mainly in unquoted venture capital holdings and aims to provide long-term tax-free returns to shareholders through a combination of dividend yield and capital growth.

Financial highlights (comparative figures as at 30 September 2022 and 31 March 2023):

  Six months endedSix months endedEighteen months ended
  30 September30 September31 March
  202320222023
     
Net assets £106.6m£106.2m£102.5m
     
Net asset value per share 61.4p63.5p62.1p
     
Return per share    
Revenue 0.2p(0.2)p(0.3)p
Capital 1.1p(2.8)p(5.7)p
Total 1.3p(3.0)p(6.0)p
     
Dividend per share declared in respect of the period 1.6p2.0p6.0p
     
Cumulative return to shareholders since launch    
Net asset value per share 61.4p63.5p62.1p
Dividends paid per share* 190.5p186.5p188.5p
Net asset value plus dividends paid per share251.9p250.0p250.6p
     
Mid-market share price at end of period 56.50p61.75p57.50p
Share price discount to net asset value 8.0%2.8%7.4%
     
Tax-free dividend yield (based on the net asset value per share)**6.3%5.4%5.4%

*Excluding interim dividend not yet paid.*\* The annualised dividend yield is calculated by dividing the dividends paid in respect of the 12 month period ended on each reference date by the net asset value per share at the start of the 12 month period.

Enquiries:James Sly, Mercia Asset Management PLC – 0330 223 1430Website: www.mercia.co.uk/vcts

HALF-YEARLY MANAGEMENT REPORT FOR THE SIX MONTH PERIOD ENDED 30 SEPTEMBER 2023

Over the past six months, the UK economy has faced numerous challenges including high inflation and little growth. Despite this backdrop, your Company has continued to provide much needed investment into early-stage companies, support for its existing portfolio companies and achieve returns through realisations.

Venture capital investment activity and portfolio updateDespite the macroeconomic backdrop, we are pleased to report that a number of our venture investments have performed well over the period, reflected in an overall increase in the valuation of the unquoted portfolio. Where portfolio companies have struggled or are at risk of failure, we have also made a number of reductions in valuations to reflect our current assessment. The listed AIM portfolio has stabilised following a decline in the previous financial period.

Further progress has been made on the development of the portfolio and deployment of our cash reserves, with two new venture capital investments totalling £3.0 million made during the six month period and £1.9 million invested in five existing portfolio companies.

One benefit of the increased interest rate environment is the yield that we are able to achieve on uninvested cash balances. In the period we liquidated the Company’s portfolio of listed shares with RBC Brewin Dolphin, placing the cash in a money market fund, and as at 30 September the blended rate achieved on uninvested cash was 4.3%. Approximately £10m of our cash was held in listed shares for almost five years and generated a compound total return of 5.0% a year over that period, significantly exceeding the rate of return available from interest rates.

We have continued to see positive realisations from portfolio companies. We have sold our holding in Evotix, for initial net proceeds of £12.7 million, representing 4.6 times return on the original cost. We have also sold our holding in Weldex (International) Offshore Holdings for proceeds of £1.6 million. The original investment in Weldex was in 1996 and this final exit represents a lifetime return (including previously received proceeds and interest) of 9.9 times. Venture investment disposals made in the six month period generated blended proceeds of 2.4 times original cost.

Results and dividendThe unaudited net asset value (NAV) per share at 30 September 2023 was 61.4 pence (62.1 pence (audited) on 31 March 2023). The total return per share before dividends for the six months ended 30 September 2023 as shown in the income statement was 1.3 pence, compared with minus 3.0 pence in the corresponding period last year. The performance was driven by an unrealised increase of £1.9 million in the valuation of investments over the last six months, along with a realised gain on disposal of investments of £0.8 million.

Five years ago, we introduced a target dividend yield of 5% of opening NAV, which has been exceeded in each of the years since then. On 18 August 2023 the final dividend of 2.0 pence in respect of the period ending 31 March 2023 was paid to shareholders. After careful consideration, and taking our target yield into account, we have decided to declare an interim dividend of 1.6 pence per share in respect of the year to 31 March 2024. The interim dividend will be paid on 17 January 2024 to shareholders on the register on 15 December 2023.

Our dividend investment scheme, which enables shareholders to invest their dividends in new ordinary shares free of dealing costs and with the benefit of the tax reliefs available on new VCT share subscriptions, continues to operate. Details on how to join the scheme are included within the dividend section of our website, which can be found here: mercia.co.uk/vcts/nvt/.

Shareholder issuesAs a result of the fully subscribed public share offer launched in January 2023, 9,741,182 new ordinary shares were issued in April 2023 for gross proceeds of £6.0 million.

We continue to experience a sustained demand for long-term growth capital for smaller companies in the UK. In order to continue to support our existing portfolio and invest in new early-stage opportunities, we are currently fundraising in conjunction with the other Northern VCTs. Full details of how to participate in the fund raise is available on the Company’s website at http://www.mercia.co.uk/vcts/.

We have maintained our policy of being willing to buy back the Company’s shares in the market in order to maintain liquidity, at a 5% discount to NAV. During the period a total of 1,836,810 shares were purchased by the Company for cancellation, representing around 1.1% of the opening ordinary share capital.

Change of registrarWe are pleased to report that from close of business on 10 November 2023 the Company changed its registrar to The City Partnership (UK) Limited (“City”). You will receive a letter confirming this change, and should you need to contact City, contact details may be found on the Company’s website.

VCT legislation and qualifying statusThe Company has continued to meet the stringent and complex qualifying conditions laid down by HM Revenue & Customs for maintaining its approval as a VCT. Mercia monitors the position closely and reports regularly to the Board. Philip Hare & Associates LLP has continued to act as independent adviser to the Company on VCT taxation matters.

The 2025 ‘sunset clause’ was a European state aid requirement that was introduced when the VCT scheme received state aid approval, which meant that without small change in legislation investors would not receive upfront tax relief when investing in VCTs after this date. We were pleased to receive the news on 22nd November 2023 that the Sunset Clause will be extended by 10 years to 2035 in the Autumn Finance Bill 2023.

OutlookWhile macroeconomic conditions remain challenging, the unquoted venture portfolio remains resilient and the Company is well capitalised, which will enable the existing portfolio to be supported as necessary. We remain confident in the long term prospects of your Company’s diversified portfolio of businesses.

On behalf of the Board

Simon ConstantineChair

INVESTMENT PORTFOLIO(Unaudited) as at 30 September 2023

 Cost£000Valuation£000% of net assetsby value
Fifteen largest venture capital investments   
Gentronix1,3624,3174.0%
Grip-UK (t/a Climbing Hangar)3,8853,8853.6%
Volumatic Holdings2163,0372.8%
Tutora (t/a Tutorful)2,7222,8722.7%
Pure Pet Food1,7742,7222.6%
Project Glow Topco (t/a Currentbody.com)1,6862,6322.5%
Newcells Biotech2,4792,6292.5%
Rockar1,8772,4882.3%
Biological Preparations Group2,3662,4172.3%
Netacea2,2922,3092.2%
Buoyant Upholstery1,1732,2012.1%
Adludio2,1032,1032.0%
Forensic Analytics2,0162,0151.9%
IDOX*2382,0021.9%
Clarilis1,9721,9721.8%
 28,161 39,60137.2%
Other venture capital investments49,73833,10531.0%
Total venture capital investments77,899 72,706 68.2%
Net current assets 33,94131.8%
Net assets 106,647100.0%

*Quoted on AIM

Extracts from the unaudited half-yearly financial statements for the six months ended 30 September 2023 are set out below.

INCOME STATEMENT(Unaudited) for the six months ended 30 September 2023

 Six months ended 30 September 2023Six months ended 30 September 2022Eighteen months ended 31 March 2023
          
 RevenueCapitalTotalRevenueCapitalTotalRevenueCapitalTotal
 £000£000£000£000£000£000£000£000£000
Gain on disposal of investments-834834-132132-2,9442,944
Movements in fair value of investments-1,9221,922-(3,983)(3,983)-(9,776)(9,776)
          
 -2,7562,756-(3,851)(3,851)-(6,832)(6,832)
          
Dividend and interest income873-873128-128948-948
Investment management fee(260)(780)(1,040)(265)(796)(1,061)(811)(2,432)(3,243)
Other expenses(345)-(345)(214)-(214)(796)-(796)
          
Return before tax2681,9762,244(351)(4,647)(4,998)(659)(9,264)(9,923)
Tax on return86(86)- ---181(181)-
          
Return after tax3541,8902,244(351)(4,647)(4,998)(478)(9,445)(9,923)
          
Return per share0.2p1.1p1.3p(0.2)p(2.8)p(3.0)p(0.3)p(5.7)p(6.0)p

BALANCE SHEET(Unaudited) as at 30 September 2023

  30 September 2023£00030 September 2022£00031 March 2023£000
Fixed assets    
Investments 72,70683,62588,609
Current assets    
Debtors 3625070
Cash and cash equivalents 33,72022,63214,001
  34,08222,68214,071
     
Creditors (amounts falling due within one year) (141)(109)(183)
Net current assets 33,94122,57313,888
     
Net assets 106,647106,198102,497
     
Capital and reserves    
Called-up equity share capital 43,45741,78141,230
Share premium 23,15919,06919,394
Capital redemption reserve 5,8014,5445,342
Capital reserve 38,66836,16034,433
Revaluation reserve (5,192)4,1721,698
Revenue reserve 754472400
Total equity shareholders’ funds 106,647106,198102,497
     
Net asset value per share 61.4p63.5p62.1p

STATEMENT OF CHANGES IN EQUITY

(Unaudited) for the six months ended 30 September 2023

  Non-distributable reserves Distributable reservesTotal
  Called-up share capital Share premium Capital redemption reserve Revaluation reserve*Capital reserve Revenue reserve  
  £000£000£000£000£000£000£000
         
         
At 1 April 2023 41,23019,3945,3421,69834,433400102,497
Return after tax --(6,890)8,7803542,244
Dividends paid ----(3,475)-(3,475)
Net proceeds of share issues 2,6863,765----6,451
Shares purchased for cancellation (459)-459-(1,070)-(1,070)
         
At 30 September 2023 43,45723,1595,801(5,192)38,668754106,647
         
         
Six months ended 30 September 2022        
         
At 1 April 2022 40,14314,9693,8339,90440,220823109,892
Return after tax ---(5,732)1,085(351)(4,998)
Dividends paid ----(3,369)-(3,369)
Net proceeds of share issues 2,3494,100----6,449
Shares purchased for cancellation (711)-711-(1,776)-(1,776)
         
At 30 September 2022 41,78119,0694,5444,17236,160472106,198
         
         
Eighteen months ended 31 March 2023        
         
At 1 October 2021 40,26814,6083,50821,43038,3251,159119,298
Return after tax ---(19,732)10,287(478)(9,923)
Dividends paid ----(9,609)(281)(9,890)
Net proceeds of share issues 2,7964,786----7,582
Shares purchased for cancellation (1,834)-1,834-(4,570)-(4,570)
         
At 31 March 2023 41,23019,3945,3421,69834,433400102,497

\* The revaluation reserve is generally non-distributable other than that part of the reserve relating to gains/losses on readily realisable quoted investments, which are distributable.STATEMENT OF CASH FLOWS(Unaudited) for the six months ended 30 September 2023

   Six months ended Six months ended Eighteen months ended
   30 September 2023 30 September 2022 31 March 2023
  £000 £000 £000
Cash flows from operating activities     
Return before tax 2,244(4,998)(9,923)
Adjustments for:    
(Gain)/loss on disposal of investments (834)(132)(2,944)
Movements in fair value of investments (1,922)3,9839,776
(Increase)/decrease in debtors (292)5238
(Decrease)/increase in creditors (42)(12)(2,496)
     
Net cash (outflow)/inflow from operating activities  (846)(1,154)(5,349)
     
Cash flows from investing activities     
Purchase of investments (5,263)(5,543)(27,450)
Sale/repayment of investments 23,9224,59228,572
     
Net cash inflow/(outflow) from investing activities  18,659(951)1,122
     
     
Cash flows from financing activities     
Issue of ordinary shares 6,6036,4807,796
Share issue expenses (152)(32)(214)
Purchase of ordinary shares for cancellation (1,070)(1,776)(4,570)
Equity dividends paid (3,475)(3,368)(9,890)
     
Net cash inflow/(outflow) from financing activities  1,9061,304(6,878)
     
     
Net increase/(decrease) in cash and cash equivalents 19,719(801)(11,105)
     
Cash and cash equivalents at beginning of period 14,00123,43325,106
     
Cash and cash equivalents at end of period  33,72022,63214,001

RISK MANAGEMENT

The Board carries out a regular and robust assessment of the risk environment in which the Company operates and seeks to identify new risks as they emerge. The principal and emerging risks and uncertainties identified by the Board which might affect the Company’s business model and future performance, and the steps taken with a view to their mitigation, are as follows:

Investment and liquidity risk: investment in smaller and unquoted companies, such as those in which the Company invests, involves a higher degree of risk than investment in larger listed companies because they generally have limited product lines, markets and financial resources and may be more dependent on key individuals. The securities of smaller companies in which the Company invests are typically unlisted, making them illiquid, and this may cause difficulties in valuing and disposing of the securities. The Company may invest in businesses whose shares are quoted on AIM – the fact that a share is quoted on AIM does not mean that it can be readily traded and the spread between the buying and selling prices of such shares may be wide.

Mitigation: the directors aim to limit the risk attaching to the portfolio as a whole by careful selection, close monitoring and timely realisation of investments, by carrying out rigorous due diligence procedures and maintaining a wide spread of holdings in terms of financing stage and industry sector within the rules of the VCT scheme. The Board reviews the investment portfolio with the investment adviser on a regular basis.

Financial risk: most of the Company’s investments involve a medium to long-term commitment and many are illiquid.

Mitigation: the directors consider that it is inappropriate to finance the Company’s activities through borrowing except on an occasional short-term basis. Accordingly they seek to maintain a proportion of the Company’s assets in cash or cash equivalents in order to be in a position to pursue new unquoted investment opportunities and to make follow-on investments in existing portfolio companies. The Company has very little direct exposure to foreign currency risk and does not enter into derivative transactions.

Economic risk: events such as economic recession or general fluctuation in stock markets, exchange rates and interest rates may affect the valuation of investee companies and their ability to access adequate financial resources, as well as affecting the Company’s own share price and discount to net asset value. The level of economic risk has been elevated most recently by inflationary pressures and interest rate increases.

Mitigation: the Company invests in a diversified portfolio of investments spanning various industry sectors, and maintains sufficient cash reserves to be able to provide additional funding to investee companies where it is appropriate and in the interests of the Company to do so. The adviser typically provides an investment executive to actively support the board of each unquoted investee company. At all times, and particularly during periods of heightened economic uncertainty, the investment executives share best practice from across the portfolio with investee management teams in order to mitigate economic risk.

Stock market risk: some of the Company’s investments are quoted on AIM and will be subject to market fluctuations upwards and downwards. External factors such as terrorist activity, political activity or global health crises, can negatively impact stock markets worldwide. In times of adverse sentiment there may be very little, if any, market demand for shares in smaller companies quoted on AIM.

Mitigation: the Company’s quoted investments are actively managed by Mercia in the case of the AIM-quoted investments, and the Board keeps the portfolio and the actions taken under ongoing review.

Credit risk: the Company holds a number of financial instruments and cash deposits and is dependent on the counterparties discharging their commitment.

Mitigation: the directors review the creditworthiness of the counterparties to these instruments and cash deposits and seek to ensure there is no undue concentration of credit risk with any one party.

Legislative and regulatory risk: in order to maintain its approval as a VCT, the Company is required to comply with current VCT legislation in the UK. Changes to UK legislation in the future could have an adverse effect on the Company’s ability to achieve satisfactory investment returns whilst retaining its VCT approval.

Mitigation: the Board and the investment adviser monitor political developments and where appropriate seek to make representations either directly or through relevant trade bodies.

Internal control risk: the Company’s assets could be at risk in the absence of an appropriate internal control regime which is able to operate effectively even during times of disruption.

Mitigation: the Board regularly reviews the system of internal controls, both financial and non-financial, operated by the Company and the investment adviser. These include controls designed to ensure that the Company’s assets are safeguarded and that proper accounting records are maintained.

VCT qualifying status risk: while it is the intention of the directors that the Company will be managed so as to continue to qualify as a VCT, there can be no guarantee that this status will be maintained. A failure to continue meeting the qualifying requirements could result in the loss of VCT tax relief, the Company losing its exemption from corporation tax on capital gains, to shareholders being liable to pay income tax on dividends received from the Company and, in certain circumstances, to shareholders being required to repay the initial income tax relief on their investment.

Mitigation: the investment adviser keeps the Company’s VCT qualifying status under continual review and its reports are reviewed by the Board on a quarterly basis. The Board has also retained Philip Hare & Associates LLP to undertake an independent VCT status monitoring role.

OTHER MATTERS

The unaudited half-yearly financial statements for the six months ended 30 September 2023 do not constitute statutory financial statements within the meaning of Section 434 of the Companies Act 2006, have not been reviewed or audited by the Company’s independent auditor and have not been delivered to the Registrar of Companies. The comparative figures for the eighteen months ended 31 March 2023 have been extracted from the audited financial statements for that period, which have been delivered to the Registrar of Companies; the independent auditor’s report on those financial statements (i) was unqualified, (ii) did not include any reference to matters to which the auditor drew attention by way of emphasis without qualifying the report and (iii) did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006. The half-yearly financial statements have been prepared on the basis of the accounting policies set out in the annual financial statements for the period ended 31 March 2023.

Each of the directors confirms that to the best of their knowledge the half-yearly financial statements have been prepared in accordance with the Statement “Half-yearly financial reports” issued by the UK Accounting Standards Board and the half-yearly financial report includes a fair review of the information required by (a) DTR 4.2.7R of the Disclosure Rules and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year, and (b) DTR 4.2.8R of the Disclosure Rules and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period, and any changes in the related party transactions described in the last annual report that could do so.

The directors of the company at the date of this statement were Mr S J Constantine (Chairman), Mr R J Green, Ms D N Hudson, and Mr D A Mayes.

The calculation of return per share is based on the return after tax for the six months ended 30 September 2023 and on 173,914,768 (30 September 2022: 168,596,795) ordinary shares, being the weighted average number of shares in issue during the period.

The calculation of net asset value per share is based on the net assets at 30 September 2023 divided by the 173,828,792 (30 September 2022: 167,123,927) ordinary shares in issue at that date.

The interim dividend of 1.6 pence per share for the year ending 31 March 2024 will be paid on 17 January 2024 to shareholders on the register on 15 December 2023.

A copy of the half-yearly financial report for the six months ended 30 September 2023 will be available to shareholders on the Mercia Asset Management PLC website.

Neither the contents of the Mercia Asset Management PLC website, nor the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website), are incorporated into, or form part of, this announcement

Date   Source Headline
4th Apr 20248:00 amGNWIssue of Equity and Total Voting Rights
28th Mar 202411:00 amGNWTotal voting rights
26th Mar 20248:00 amGNWDirectorate changes
21st Mar 20243:00 pmGNWTransaction in Own Shares
6th Mar 20244:30 pmGNWTransaction in Own Shares
29th Feb 202411:00 amGNWTotal voting rights
23rd Feb 20248:00 amGNWOffer Update
9th Feb 20248:00 amGNWNet Asset Value
31st Jan 202411:00 amGNWTotal voting rights
17th Jan 20248:00 amGNWIssue of Equity and Total Voting Rights
29th Dec 202311:00 amGNWTotal voting rights
7th Dec 202311:00 amGNWDirector/PDMR Shareholding
7th Dec 202311:00 amGNWDirector/PDMR Shareholding
7th Dec 202310:00 amGNWIssue of Equity and Total Voting Rights
5th Dec 20234:15 pmGNWTransaction in Own Shares
30th Nov 202311:00 amGNWTotal voting rights
28th Nov 20238:00 amGNWOffer Update – Utilisation of Over-Allotment Facility
23rd Nov 20232:02 pmGNWDividend Declaration
23rd Nov 20232:01 pmGNWHalf-yearly report
23rd Nov 20232:00 pmGNWUnaudited Half-Yearly Financial Report for the Six Month Period Ended 30 September 2023
13th Nov 202310:00 amGNWStatement re change in registrar
31st Oct 202311:00 amGNWTotal voting rights
29th Sep 20239:00 amGNWTotal voting rights
27th Sep 20234:00 pmGNWTransaction in Own Shares
27th Sep 20238:00 amGNWOffer for subscription
18th Sep 20231:00 pmGNWPublication of Prospectus
31st Aug 202311:00 amGNWTotal voting rights
18th Aug 20238:00 amGNWIssue of Equity and Total Voting Rights
31st Jul 202311:00 amGNWTotal voting rights
28th Jul 20233:30 pmGNWNet Asset Value
21st Jul 20232:31 pmGNWResult of General Meeting
21st Jul 20232:30 pmGNWResult of AGM
14th Jul 20238:30 amGNWTransaction in Own Shares
30th Jun 202311:00 amGNWTotal voting rights
26th Jun 20233:31 pmGNWNotice of General Meeting
26th Jun 20233:30 pmGNWAnnual Report and Notice of AGM
15th Jun 20233:02 pmGNWStatement regarding intention to fund raise
15th Jun 20233:01 pmGNWDividend Declaration
15th Jun 20233:00 pmGNWAnnual Financial Report for the Period Ended 31 March 2023
31st May 202311:00 amGNWTotal voting rights
28th Apr 202311:00 amGNWTotal voting rights
4th Apr 20237:15 amGNWDirector/PDMR Shareholding
4th Apr 20237:15 amGNWDirector/PDMR Shareholding
4th Apr 20237:00 amGNWIssue of Equity and Total Voting Rights
31st Mar 202311:00 amGNWTotal voting rights
28th Mar 20235:00 pmGNWTransaction in Own Shares
28th Feb 202311:00 amGNWTotal voting rights
28th Feb 20237:00 amGNWOffer Update
21st Feb 20235:30 pmGNWTransaction in Own Shares
10th Feb 202311:00 amGNWNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.